- Else Nutrition Holdings Inc. (TSX: BABY) (OTCQX: BABYF) launches 'Formula for Change' campaign in the U.S.
- Aims to modernize U.S. regulations for dairy-free, soy-free infant formula clinical trials.
- Seeks to provide more options following the 2022-2023 formula shortage crisis.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF), a global leader in plant-based childhood nutrition, has announced the launch of its 'Formula for Change' campaign. The initiative aims to garner support for U.S. regulatory approval of clinical trials for its groundbreaking dairy-free and soy-free infant formula. The campaign builds on the federal effort titled Operation Stork Speed, which seeks to fast-track next-generation infant formula development.
The company's unique formula is the world's first to use whole plant ingredients, like almonds and buckwheat, effectively mimicking the nutritional profile of human milk. Notably, it holds the Clean Label Project Purity Award for safety. Despite international availability, current U.S. regulations do not allow clinical trials necessary for market approval.
Key objectives of the 'Formula for Change' campaign include modernizing outdated U.S. regulatory pathways, addressing market concentration dominated by four main companies, and offering alternatives for infants intolerant to dairy and soy. The initiative also aims to prevent future shortages similar to the 2022-2023 formula crisis.
"We've already heard from countless U.S. families how our toddler formula has positively impacted their children," said Hamutal Yitzhak, CEO of Else Nutrition. "Operation Stork Speed gives us hope—but hope needs action. Modernizing regulatory pathways is the crucial next step to enable innovation for the babies who need it most."
Else Nutrition is actively mobilizing parents, pediatric professionals, and policymakers to advocate for inclusive, evidence-based nutrition. The company encourages public support to prompt regulatory updates, which would facilitate the introduction of their revolutionary formula to the U.S. market.
